Edition:
United States

NovaBay Pharmaceuticals Inc (NBY.A)

NBY.A on American Stock Exchange

2.50USD
22 May 2017
Change (% chg)

$-0.35 (-12.28%)
Prev Close
$2.85
Open
$2.80
Day's High
$2.80
Day's Low
$2.50
Volume
8,176
Avg. Vol
3,200
52-wk High
$5.05
52-wk Low
$2.12

NBY.A

Chart for NBY.A

About

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a... (more)

Overall

Beta: -0.48
Market Cap(Mil.): $44.29
Shares Outstanding(Mil.): 15.31
Dividend: --
Yield (%): --

Financials

  NBY.A Industry Sector
P/E (TTM): -- 142.93 17.37
EPS (TTM): -1.08 -- --
ROI: -260.37 2.34 -5.89
ROE: -- 0.22 -5.30

BRIEF-Novabay Pharmaceuticals reports Q1 loss per share $0.26

* Novabay Pharmaceuticals reports first quarter 2017 financial results

May 11 2017

BRIEF-Novabay Pharmaceuticals sees FY 2017 revenue $19 million

* Novabay Pharmaceuticals reports 2016 full year and fourth quarter financial results and provides 2017 financial guidance

Mar 23 2017

More From Around the Web

Competitors

  Price Chg
Realm Therapeutics PLC (RLM.L) 31.68 +0.43
C R Bard Inc (BCR.N) $307.65 +0.10
Smith & Nephew plc (SN.L) 1,333.00 +6.00
Abbott Laboratories (ABT.N) $43.48 +0.32
GlaxoSmithKline plc (GSK.L) 1,647.19 -0.31
3M Co (MMM.N) $197.97 +2.17
Sanofi SA (SASY.PA) €87.76 -0.62
Pfizer Inc. (PFE.N) $32.37 -0.09
Novartis AG (NOVN.S) CHF79.40 +0.65
Johnson & Johnson (JNJ.N) $127.55 +0.55

Earnings vs. Estimates